Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumor × Drug Therapy × Clear all

Phase

Phase NA 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 70 Breast Neoplasms 30 Rectal Neoplasms 21 Colorectal Neoplasms 20 Lung Neoplasms 19 Neoplasms 18 Esophageal Squamous Cell Carcinoma 18 Neoplasm Metastasis 15 Head and Neck Neoplasms 15 Esophageal Neoplasms 15 Stomach Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 12 Pancreatic Neoplasms 12 Triple Negative Breast Neoplasms 11 Small Cell Lung Carcinoma 11 Ovarian Neoplasms 11 Carcinoma, Squamous Cell 10 Nasopharyngeal Carcinoma 9 Colonic Neoplasms 8 Recurrence 7 Prostatic Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma 7 Leukemia, Myeloid, Acute 7 Sarcoma 6 Lymphoma, Non-Hodgkin 6 Uterine Cervical Neoplasms 5 Fallopian Tube Neoplasms 5 Cholangiocarcinoma 5 Carcinoma, Ovarian Epithelial 5

Interventions

apatinib 3 vistusertib 2 olaparib 2 camrelizumab 2 atezolizumab 2 Ipilimumab 2 Everolimus 2 trametinib 1 tilsotolimod 1 tazemetostat 1 tazarotene 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 rucaparib 1 roniciclib 1 romiplostim 1 pyrotinib 1 phosphorylethanolamine 1 pemigatinib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 niraparib 1 magrolimab 1 lenvatinib 1 irinotecan sucrosofate 1 famitinib 1 dalpiciclib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05898451 2023-06-12

R-2

Refnot-Pharm Ltd

Phase 2 Completed

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡